Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up and catch-up immunization study of 10-valent pneumococcal conjugate vaccine in children
2008-008104-41Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2009
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of 10-valent pneumococcal conjugate vaccine in pneumococcal disease (2 arms), sponsored by GSK. Primary endpoints: Early immune response after additional or first study dose and Immunological memory. Started Apr 2009; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2008-008104-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008104-41.